LifeMine Therapeutics Company
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Technology:
['BioTech & HealthTech']
Headquarters:
Cambridge, Massachusetts, United States
Last Funding Date:
2022-03-23
Total Funding:
295000000.0
Last Funding Type:
Series C
Founded Date:
2016-01-01
Investors Number:
14.0
Industry:
Medical BioTech
Employee Number:
51-100
Estimated Revenue:
$1M to $10M
Funding Status:
Late Stage Venture